Literature DB >> 20375600

The innate immune response: an important partner in shaping coxsackievirus-mediated autoimmunity.

Martin J Richer1, Marc S Horwitz.   

Abstract

To protect against viral infection, the immune response is critically dependent on innate sensing mechanisms to provide rapid detection of pathogens and allow for the development of an appropriate adaptive immune response. Mounting evidence suggests that mechanistic differences in the sensing of viruses by the innate immune response can contribute to the development of autoimmunity. Coxsackieviruses are common human pathogens that have been linked to the induction of autoimmune diseases such as chronic autoimmune myocarditis and type 1 diabetes. In this review, we will discuss the current knowledge of the interactions between coxsackievirus and the innate immune system and how these interactions can potentially lead to the induction of autoimmune diseases. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 20375600     DOI: 10.1159/000226247

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  4 in total

Review 1.  Virus infections and type 1 diabetes risk.

Authors:  Merja Roivainen; Karin Klingel
Journal:  Curr Diab Rep       Date:  2010-10       Impact factor: 4.810

Review 2.  Polymorphisms in genes encoding nonsarcomeric proteins and their role in the pathogenesis of dilated cardiomyopathy.

Authors:  J Staab; V Ruppert; S Pankuweit; T Meyer
Journal:  Herz       Date:  2012-12       Impact factor: 1.443

3.  Concurrent Coxsackie Virus A6 Infection and Kawasaki Disease.

Authors:  Hiro Matsukura; Serina Majima; Tomoko Sakuma
Journal:  Indian Pediatr       Date:  2022-08-15       Impact factor: 3.839

4.  Expression of innate immunity genes and damage of primary human pancreatic islets by epidemic strains of Echovirus: implication for post-virus islet autoimmunity.

Authors:  Luis Sarmiento; Gun Frisk; Mahesh Anagandula; Eduardo Cabrera-Rode; Merja Roivainen; Corrado M Cilio
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.